Institutional investors purchased a net $1.7 million shares of NLNK during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 46.98% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 822.6 Thousand shares of NewLink Genetics Corp
FRANKLIN ADVISERS, INC. Bought 772.1 Thousand shares of NewLink Genetics Corp
PYRAMIS GLOBAL ADVISORS LLC Bought 720.4 Thousand shares of NewLink Genetics Corp